Eli Lilly Drug Shows Promise in Treating Mild Alzheimer’s

Tuesday, October 9, 2012 - 00:50 in Health & Medicine

Results from two studies of Eli Lilly’s solanezumab suggested it may slow mental decline, but doctors said another study was probably necessary for federal approval.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net